Envudeucitinib for Active Systemic Lupus Erythematosus

Envudeucitinib for Active Systemic Lupus Erythematosus
41%30%19%May 18May 19May 20May 21May 22May 23May 24May 25May 26May 27May 27 • YES 29.9%
Alumis Inc ($ALMS)
No stock close$22.52$21.74$20.96May 18May 19May 20May 21May 22May 23May 24May 25May 26May 27May 18 • ALMS $21.15May 19 • ALMS $21.53May 20 • ALMS $22.04May 21 • ALMS $22.17May 22 • ALMS $22.02May 26 • ALMS $22.33May 27 • ALMS $21.50

Will this trial show a positive result on proportion of patients with BICLA lupus disease-activity response at Week 48?

Paper Trading
Create account to trade
ClinicalNewsTrialPositionsReasoningOracle
No oracle findings have been stored for this trial yet.
Stats
Latest Run
No runs yet
Model
No runs yet
Runs
0 runs